Health-related quality of life from the MM-003 trial of pomalidomide plus low-dose dexamethasone versus high-dose dexamethasone in relapsed and/or refractory multiple myeloma

被引：24
|
作者：
Song, Kevin W. [1 ]
Dimopoulos, Meletios A. [2 ]
Weisel, Katja C. [3 ]
Moreau, Philippe [4 ]
Palumbo, Antonio [5 ,6 ]
Belch, Andrew [7 ]
Schey, Stephen [8 ,9 ]
Sonneveld, Pieter [10 ]
Sternas, Lars [11 ]
Yu, Xin [11 ]
Amatya, Ramesh [12 ]
Monzini, Mara S. [11 ]
Zaki, Mohamed [11 ]
Jacques, Christian [11 ]
Miguel, Jesus San [13 ]
机构：
[1] Vancouver Gen Hosp, Vancouver, BC, Canada
[2] Alexandra Hosp, Athens, Greece
[3] Univ Tubingen Hosp, Tubingen, Germany
[4] Univ Hosp Hotel Dieu, Nantes, France
[5] Univ Hosp, Milan, Italy
[6] Hlth City Sci Torino, Turin, Italy
[7] Univ Alberta, Edmonton, AB, Canada
[8] Kings Coll Hosp London, London, England
[9] Kings Coll London, London WC2R 2LS, England
[10] Erasmus MC, Rotterdam, Netherlands
[11] Celgene Corp, Summit, NJ USA
[12] Adelphi Values, Boston, MA USA
[13] Hosp Univ Salamanca, Salamanca, Spain
来源：
HAEMATOLOGICA | 2015年 / 100卷 / 02期
关键词：
Pomalidomide; quality of life; multiple myeloma; EORTC QLQ-C30; SURVIVAL; BORTEZOMIB; DISEASE; EQ-5D;
D O I：
10.3324/haematol.2014.112557
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：E63 / E67
页数：5
相关论文
共 50 条
  • [1] Analysis of renal impairment in MM-003, a phase III study of pomalidomide plus low-dose dexamethasone versus high-dose dexamethasone in refractory or relapsed and refractory multiple myeloma
    Weisel, Katja C.
    Dimopoulos, Meletios A.
    Moreau, Philippe
    Lacy, Martha Q.
    Song, Kevin W.
    Delforge, Michel
    Karlin, Lionel
    Goldschmidt, Hartmut
    Banos, Anne
    Oriol, Albert
    Alegre, Adrian
    Chen, Christine
    Cavo, Michele
    Garderet, Laurent
    Ivanova, Valentina
    Martinez-Lopez, Joaquin
    Knop, Stefan
    Yu, Xin
    Hong, Kevin
    Sternas, Lars
    Jacques, Christian
    Zaki, Mohamed H.
    Miguel, Jesus San
    [J]. HAEMATOLOGICA, 2016, 101 (07) : 872 - 878
  • [2] Pomalidomide plus low-dose dexamethasone (POM plus LoDEX) versus high-dose dexamethasone (HiDEX) in relapsed/refractory multiple myeloma (RRMM): Impact of cytogenetics in MM-003
    Goldschmidt, Hartmut
    Dimopoulos, Meletios A.
    Weisel, Katja C.
    Moreau, Philippe
    Lacy, Martha
    Song, Kevin W.
    Delforge, Michel
    Karlin, Lionel
    Banos, Anne
    Rocafiguera, Albert Oriol
    Yu, Xin
    Sternas, Lars
    Jacques, Christian
    Zaki, Mohamed H.
    San-Miguel, Jesus F.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [3] OVERALL SURVIVAL OF PATIENTS WITH RELAPSED AND REFRACTORY MULTIPLE MYELOMA: ADJUSTING FOR CROSSOVER IN THE MM-003 TRIAL FOR POMALIDOMIDE PLUS LOW-DOSE DEXAMETHASONE VS. HIGH-DOSE DEXAMETHASONE
    Morgan, G.
    San Miguel, J. F.
    Dhanasiri, S.
    Lee, D.
    Palumbo, A.
    Facon, T.
    Zaki, M.
    Yu, X.
    Sternas, L.
    Jacques, C.
    Weisel, K.
    Offner, F.
    Dimopoulos, M.
    [J]. HAEMATOLOGICA, 2014, 99 : 365 - 366
  • [4] Pomalidomide plus low-dose dexamethasone versus high-dose dexamethasone alone for patients with relapsed and refractory multiple myeloma (MM-003): a randomised, open-label, phase 3 trial
    San Miguel, Jesus
    Weisel, Katja
    Moreau, Philippe
    Lacy, Martha
    Song, Kevin
    Delforge, Michel
    Karlin, Lionel
    Goldschmidt, Hartmut
    Banos, Anne
    Oriol, Albert
    Alegre, Adrian
    Chen, Christine
    Cavo, Michele
    Garderet, Laurent
    Ivanova, Valentina
    Martinez-Lopez, Joaquin
    Belch, Andrew
    Palumbo, Antonio
    Schey, Stephen
    Sonneveld, Pieter
    Yu, Xin
    Sternas, Lars
    Jacques, Christian
    Zaki, Mohamed
    Dimopoulos, Meletios
    [J]. LANCET ONCOLOGY, 2013, 14 (11): : 1055 - 1066
  • [5] CYTOGENETICS AND LONG-TERM SURVIVAL IN MM-003, A PHASE 3 TRIAL OF POMALIDOMIDE plus LOW-DOSE DEXAMETHASONE VS. HIGH-DOSE DEXAMETHASONE IN REFRACTORY OR RELAPSED AND REFRACTORY MULTIPLE MYELOMA
    Dimopoulos, M. A.
    Weisel, K.
    Song, K. W.
    Delforge, M.
    Karlin, L.
    Goldschmidt, H.
    Moreau, P.
    Banos, A.
    Oriol, A.
    Garderet, L.
    Cavo, M.
    Ivanova, V.
    Alegre, A.
    Martinez-Lopez, J.
    Chen, C. I.
    Spencer, A.
    Knop, S.
    Bahlis, N. J.
    Renner, C.
    Yu, X.
    Hong, K.
    Sternas, L.
    Jacques, C.
    Zaki, M. H.
    San Miguel, J. F.
    [J]. HAEMATOLOGICA, 2014, 99 : 365 - 365
  • [6] Pomalidomide (POM) Plus Low-Dose Dexamethasone (LoDEX) Improves Health-Related Quality Of Life (HRQoL) Vs High-Dose Dexamethasone (HiDEX) In Relapsed Refractory Multiple Myeloma (RRMM) Patients Enrolled In MM-003 Phase 3 Randomized Trial
    Song, Kevin W.
    Dimopoulos, Meletios A.
    Weisel, Katja
    Delforge, Michel
    Karlin, Lionel
    Goldschmidt, Hartmut
    Moreau, Philippe
    Banos, Anne
    Oriol, Albert
    Spencer, Andrew
    Knop, Stefan
    Renner, Christoph
    Bahlis, Nizar J.
    Amatya, Ramesh
    Yu, Xin
    Monzini, Mara Silvia
    Sternas, Lars
    Zaki, Mohamed H.
    Jacques, Christian J.
    San Miguel, Jesus F.
    [J]. BLOOD, 2013, 122 (21)
  • [7] Overall survival of relapsed and refractory multiple myeloma patients after adjusting for crossover in the MM-003 trial for pomalidomide plus low-dose dexamethasone
    Morgan, Gareth
    Palumbo, Antonio
    Dhanasiri, Sujith
    Lee, Dawn
    Weisel, Katja
    Facon, Thierry
    Delforge, Michel
    Oriol, Albert
    Zaki, Mohamed
    Yu, Xin
    Sternas, Lars
    Jacques, Christian
    Akehurst, Ron
    Offner, Fritz
    Dimopoulos, Meletios A.
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2015, 168 (06) : 820 - 823
  • [8] MM-003, A PHASE 3 STUDY OF POMALIDOMIDE plus LOW-DOSE DEXAMETHASONE VS. HIGH-DOSE DEXAMETHASONE IN REFRACTORY OR RELAPSED AND REFRACTORY MULTIPLE MYELOMA: OUTCOMES BY PRIOR THERAPY AND RESPONSE DEPTH
    San Miguel, J. F.
    Weisel, K. C.
    Song, K. W.
    Delforge, M.
    Karlin, L.
    Goldschmidt, H.
    Moreau, P.
    Banos, A.
    Oriol, A.
    Garderet, L.
    Cavo, M.
    Ivanova, V.
    Alegre, A.
    Martinez-Lopez, J.
    Chen, C. I.
    Renner, C.
    Bahlis, N. Jacques
    Yu, X.
    Teasdale, T.
    Sternas, L.
    Jacques, C.
    Zaki, M. H.
    Dimopoulos, M. A.
    [J]. HAEMATOLOGICA, 2014, 99 : 110 - 110
  • [9] Pomalidomide plus low-dose dexamethasone (POM plus LoDEX) versus high-dose dexamethasone (HiDEX) in relapsed/refractory multiple myeloma (RRMM): MM-003 analysis of patients (pts) with moderate renal impairment (RI)
    Weisel, Katja C.
    Dimopoulos, Meletios A.
    Moreau, Philippe
    Lacy, Martha
    Song, Kevin W.
    Delforge, Michel
    Karlin, Lionel
    Goldschmidt, Hartmut
    Banos, Anne
    Rocafiguera, Albert Oriol
    Yu, Xin
    Sternas, Lars
    Jacques, Christian
    Zaki, Mohamed H.
    San-Miguel, Jesus F.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [10] Impact of prior treatment and depth of response on survival in MM-003, a randomized phase 3 study comparing pomalidomide plus low-dose dexamethasone versus high-dose dexamethasone in relapsed/refractory multiple myeloma
    San Miguel, Jesus F.
    Weisel, Katja C.
    Song, Kevin W.
    Delforge, Michel
    Karlin, Lionel
    Goldschmidt, Hartmut
    Moreau, Philippe
    Banos, Anne
    Oriol, Albert
    Garderet, Laurent
    Cavo, Michele
    Ivanova, Valentina
    Alegre, Adrian
    Martinez-Lopez, Joaquin
    Chen, Christine
    Renner, Christoph
    Bahlis, Nizar Jacques
    Yu, Xin
    Teasdale, Terri
    Sternas, Lars
    Jacques, Christian
    Zaki, Mohamed H.
    Dimopoulos, Meletios A.
    [J]. HAEMATOLOGICA, 2015, 100 (10) : 1334 - 1339
12345